Study
Specific BRCA and immune configurations determine optimal response to platinum-based chemotherapy in triple negative breast and ovarian carcinomas (COH TNBC RNAseq)
| Study ID | Alternative Stable ID | Type |
|---|---|---|
| EGAS00001006002 | Other |
Study Description
To determine the trascriptional profiles of Triple Negative Breast Cancers (COH cohort)
Study Datasets 1 dataset.
Click on a Dataset ID in the table below to learn more, and to find out who to contact about access to these data
| Dataset ID | Description | Technology | Samples |
|---|---|---|---|
| EGAD00001008542 |
RNAseq data relative to 41 triple negative breast cancer patients.
|
Illumina HiSeq 4000 | 41 |
Who archives the data?
Publications
Citations
Retrieving...
Retrieving...
